HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.

Abstract
The Epstein-Barr virus (EBV) is a ubiquitous B-lymphotropic herpesvirus associated with several malignant tumors, e.g., Burkitt's lymphoma and Hodgkin's disease, and is able to efficiently immortalize primary B lymphocytes in vitro. The growth program of infected B cells is initiated and maintained by the viral transcription factor EBV nuclear antigen 2 (EBNA2), which regulates viral and cellular genes, including the proto-oncogene c-myc. In our study, patterns of protein expression in B cells with and without EBNA2 were analyzed by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. For this purpose, we used a conditional immortalization system for EBV, a B cell line (EREB2-5) that expresses an estrogen receptor-EBNA2 fusion protein. In order to discriminate downstream targets of c-Myc from c-Myc-independent EBNA2 targets, we used an EREB2-5-derived cell line, P493-6, in which c-Myc is expressed under the control of a tetracycline-regulated promoter. Of 20 identified EBNA2 target proteins, 11 were c-Myc dependent and therefore most probably associated with proliferation, and one of these proteins was a posttranslationally modified protein, i.e., hypusinylated eIF5a. Finally, to estimate the relevance of EBNA2 targets during early EBV infection, we analyzed the proteomes of primary B cells before and after infection with EBV. The protein expression pattern induced upon EBV infection was similar to that following EBNA2 activation. These findings underscore the value of EREB2-5 cells as an appropriate model system for the analysis of early events in the process of EBV-mediated B-cell immortalization.
AuthorsMartin Schlee, Tanja Krug, Olivier Gires, Reinhard Zeidler, Wolfgang Hammerschmidt, Reinhard Mailhammer, Gerhard Laux, Guido Sauer, Josip Lovric, Georg W Bornkamm
JournalJournal of virology (J Virol) Vol. 78 Issue 8 Pg. 3941-52 (Apr 2004) ISSN: 0022-538X [Print] United States
PMID15047810 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Viral
  • EBNA-2 protein, Human herpesvirus 4
  • Epstein-Barr Virus Nuclear Antigens
  • MAS1 protein, human
  • Proteome
  • Proto-Oncogene Mas
  • Viral Proteins
Topics
  • B-Lymphocytes (cytology, virology)
  • Base Sequence
  • Cell Transformation, Viral
  • DNA, Viral (genetics)
  • Epstein-Barr Virus Infections (genetics, metabolism, virology)
  • Epstein-Barr Virus Nuclear Antigens (genetics, physiology)
  • Gene Expression
  • Genes, myc
  • Herpesvirus 4, Human (pathogenicity, physiology)
  • Humans
  • In Vitro Techniques
  • Protein Biosynthesis
  • Proteome
  • Proto-Oncogene Mas
  • Viral Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: